Ladon Therapeutics is a clinical stage biopharmaceutical company.

Ladon discovers, develops and commercializes A3SMO® (Artificial Amino Acid-based Small Molecules) first-in-class medicines and diagnostics for autoimmune and genetic diseases with major unmet medical needs.

Ladon brings together breakthrough Artificial Amino Acid-based Small Molecule chemistry and a state-of-the-art diagnostic laboratory from gene expression profiling to in vivo disease models to characterize, test and evaluate A3SMO® drug candidates.

Ladon Therapeutics

Org chart

Teams

Offices